9 months ago
37
(NewsNation) — The fashionable value nonaccomplishment drugs Ozempic and Wegovy whitethorn trim the rates of terrible COVID-19 reactions, including death, a caller survey found.
Published successful the Journal of the American College of Cardiology, the proceedings examined 17,604 people implicit much than 3 years.
It recovered that, portion taking semaglutide erstwhile a play did not trim rates of COVID-19 overall, it led to less "COVID-19 related adverse events."
Placebo-takers recorded a 3.1% occurrence, portion those connected the value nonaccomplishment drugs noted 2.6%.
Participants were:
- 45 years oregon older
- Overweight oregon had obesity
- Diagnosed with cardiovascular disease
- Not diagnosed with diabetes
Approximately 833 full deaths occurred during the trial. Of those deaths, 58% were cardiovascular illness related portion 42% weren't.
"In general, determination were consistently little rates of all-cause death, CV death, and non-CV decease successful patients assigned to semaglutide compared with placebo crossed large subgroups, including by age, sex, race, region, atherosclerotic illness areas, renal function, oregon bosom failure," the survey concluded.
"These findings reenforce that overweight and obesity increases the hazard of decease owed to galore etiologies, which tin beryllium modified with potent incretin-based therapies similar semaglutide," said Benjamin Scirica, MD, MPH, pb writer of the study, according to MedicalXpress reporting.
